Desenvolupament i creixement
Objectiu Estratègic
Pretén estudiar les bases biològiques de la repercussió que provoquen les anomalies, malalties i tractaments en el creixement i desenvolupament dels nens. En concret, analitzen la relació entre el retard de creixement intrauterí i les alteracions endocrinometabòliques, les conseqüències futures de les anomalies diagnosticades prenatalment i la seva prevenció, les bases moleculars i genètiques de l’oncologia pediàtrica, el trasplantament d’ovari com a mètode de preservació de la funció ovàrica, i l’estudi de l’efecte d’alguns agents infecciosos i, en especial, el VIH en l’edat pediàtrica.
Publicacions
Álvarez A, Toll T, Rives S, Estella J. Assessment of neutrophil activation in whole blood by flow cytometry. Clin Lab Haematol 2005 ; 27 (1) : 41-46. Original
Factor impacte: 0, 612
Cepero S, Ullot R, Sastre S. Osteochondritis of the femoral condyles in children and adolescents: our experience over the last 28 years. J Pediatr Orthoped B 2005 ; 14 (1) : 24-29. Original
Factor impacte: 0,347
Juncosa T, Fumadó V, Martín J, Palacín E. Virus de la hepatitis B en niños adoptados o inmigrantes en Cataluña. Med Clin (Barc) 2005 ; 124 (5) : 196. Carta
Factor impacte: 1,018
Arostegui E, Aldea A, Modesto C, Rua MJ, Arguelles F, González Enseñat MA, Ramos E, Rius J, Plaza S, Vives J, Yague J. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum 2004 ; 50 (12) : 4045-50. Original
Factor impacte: 7,190
De José Maria B, Tielens LK. Vertical infraclavicular brachial plexus block in children: a preliminary study. Paediatr Anaesth 2004 ; 14 (11) : 931-935. Original
Factor impacte: 0,983
Figueras Aloy J, Carbonell X, Quero J. IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J 2004 ; 23 (9) : 821-823. Estudi multicèntric
Factor impacte: 2, 262
Gené A, García-García JJ, Sala P, Sierra M, Huguet R. Enhanced culture detection of kingella kingae, a pathogen of increasing clinical importance in pediatrics. Pediatr Infect Dis J 2004 ; 23 (9) : 886-888. Original
Factor impacte: 2,262
Guillén A, Costa JM. Spontaneous resolution of a Chiari I malformation associated syringomyelia in one child. Acta Neurochir (Wien) 2004 ; 146 (2) : 187-191. Cas clínic
Factor impacte: 0,977
Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, García Consuegra J, Dolezalova P, Dressler F, Duzova A, Ferriani VP, Hilario MO, Ibanez-Rubio M, Kasapcopur O, Kuis W, Lehman TJ, Nemcova D, Nielsen S, Oliveira SK, Schikler K, Sztajnbok F, Terreri MT, Zulian F, Woo P. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 2004 ; 145 (4) : 517-22. Original
Factor impacte: 2,913
Reitamo S, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, Smith C, Moss C, Dobozy A, Palatsi R. European Tacrolimus Ointment Group. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol 2004 ; 150 (3) : 554-62. Estudi multicèntric
Factor impacte: 2,659
Romera G, Figueras Aloy J, Rodríguez Miguélez JM, Ortega J, Jiménez González R. Energy intake, metabolic balance and growth in preterm infants fed formulas with different nonprotein energy supplements. J Pediatr Gastroenterol Nutr 2004 ; 38 (4) : 407-413. Original
Factor impacte: 1,402
Vicente Gutiérrez MP, Pons Odena M, Medina M. Pulmonary involvement in tuberous sclerosis. Pediatr Pulm 2004 ; 37 (2) : 178-180. Original
Factor impacte: 1,917
Ajuts a la recerca actius
Alda J. Seguridad y tolerancia de los fármacos antipsicóticos en niños y adolescentes. Fondo de Investigación Sanitaria. 28/12/2004-27/12/2007
Capdevila A. Web accessible MR desition support system for Brain tumour diagnosis and prognosis, incoporating in vivo and ex vivo genomic and metabolomic data (eTumour). Unió Europea. 01/01/2004-31/1/2009
